Epclusa and Ketoconazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Epclusa (sofosbuvir; velpatasvir) and Ketoconazole (ketoconazole). Common drug interactions include blood pressure inadequately controlled among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Epclusa and Ketoconazole. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Epclusa?

Epclusa has active ingredients of sofosbuvir; velpatasvir. eHealthMe is studying from 12,120 Epclusa users. Check the latest studies of Epclusa.

What is Ketoconazole?

Ketoconazole has active ingredients of ketoconazole. It is often used in fungal infection. eHealthMe is studying from 16,014 Ketoconazole users. Check the latest studies of Ketoconazole.



On Jul, 12, 2026

17 people who take Epclusa and Ketoconazole together, and have interactions are studied.

Epclusa and Ketoconazole drug interactions.

What are the common drug interactions of Epclusa and Ketoconazole, by gender? *:

female:

  1. Blood pressure inadequately controlled
  2. Catheter site pain
  3. Hyperkalaemia (damage to or disease of the kidney)
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Anxiety
  6. Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness)
  7. Abdominal pain
  8. Blood iron increased
  9. Catheter site erythema (redness of skin at catheter site)
  10. Depression

male:

  1. Fatigue (feeling of tiredness)
  2. Vomiting
  3. Hallucination (an experience involving the perception of something not present)
  4. Headache (pain in head)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Muscle spasms (muscle contraction)
  7. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Pain
  10. Renal failure (kidney dysfunction)

What are the common drug interactions of Epclusa and Ketoconazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Blood pressure inadequately controlled
  3. Catheter site pain
  4. Erythema (redness of the skin)
  5. Hyperkalaemia (damage to or disease of the kidney)
  6. Renal impairment (severely reduced kidney function)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Skin disorder (skin disease)
  9. Skin infection
  10. Soft tissue infection

50-59:

  1. Bone density decreased
  2. Chronic kidney disease
  3. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  4. Emotional distress
  5. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  6. Hallucination (an experience involving the perception of something not present)
  7. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Pain
  10. Renal failure (kidney dysfunction)

60+:

  1. Fatigue (feeling of tiredness)
  2. Chest pain
  3. Headache (pain in head)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Muscle spasms (muscle contraction)
  6. Vomiting
  7. Abdominal discomfort
  8. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 23.53%
  2. Hiv Infection: 2 people, 11.76%
  3. Hepatitis C: 2 people, 11.76%
  4. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Epclusa and Ketoconazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Epclusa and Ketoconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Epclusa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ketoconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Epclusa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ketoconazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sofosbuvir; velpatasvir and ketoconazole (the active ingredients of Epclusa and Ketoconazole, respectively), and Epclusa and Ketoconazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: